Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Observing movement disorders: best practice proposal in the use of video recording in clinical practice.

Sambati L, Baldelli L, Calandra Buonaura G, Capellari S, Giannini G, Scaglione CLM, Armaroli M, Zoni E, Cortelli P, Martinelli P.

Neurol Sci. 2019 Feb;40(2):333-338. doi: 10.1007/s10072-018-3639-0. Epub 2018 Nov 17.

PMID:
30448965
2.

Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease.

Contin M, Lopane G, Mohamed S, Calandra-Buonaura G, Capellari S, De Massis P, Nassetti S, Perrone A, Riva R, Sambati L, Scaglione C, Cortelli P.

Parkinsonism Relat Disord. 2019 Apr;61:111-117. doi: 10.1016/j.parkreldis.2018.11.007. Epub 2018 Nov 8.

PMID:
30446407
3.

Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia.

Defazio G, Albanese A, Pellicciari R, Scaglione CL, Esposito M, Morgante F, Abbruzzese G, Bentivoglio AR, Bono F, Coletti Moja M, Fabbrini G, Girlanda P, Lopiano L, Pacchetti C, Romano M, Fadda L, Berardelli A.

Neurol Sci. 2019 Jan;40(1):89-95. doi: 10.1007/s10072-018-3586-9. Epub 2018 Sep 29.

PMID:
30269178
4.

Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.

Donadio V, Incensi A, El-Agnaf O, Rizzo G, Vaikath N, Del Sorbo F, Scaglione C, Capellari S, Elia A, Stanzani Maserati M, Pantieri R, Liguori R.

Sci Rep. 2018 Sep 24;8(1):14246. doi: 10.1038/s41598-018-32588-8.

5.

Skin Nerve Phosphorylated α-Synuclein Deposits in Parkinson Disease With Orthostatic Hypotension.

Donadio V, Incensi A, Del Sorbo F, Rizzo G, Infante R, Scaglione C, Modugno N, Fileccia E, Elia AE, Cencini F, Liguori R.

J Neuropathol Exp Neurol. 2018 Oct 1;77(10):942-949. doi: 10.1093/jnen/nly074.

PMID:
30137426
6.

Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia.

Esposito M, Fabbrini G, Ferrazzano G, Berardelli A, Peluso S, Cesari U, Gigante AF, Bentivoglio AR, Petracca M, Erro R, Barone P, Schirinzi T, Eleopra R, Avanzino L, Romano M, Scaglione CL, Cossu G, Morgante F, Minafra B, Zibetti M, Coletti Moja M, Turla M, Fadda L, Defazio G.

Eur J Neurol. 2018 Nov;25(11):1341-1344. doi: 10.1111/ene.13731. Epub 2018 Jul 31.

PMID:
29935029
7.

Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings.

Defazio G, Esposito M, Abbruzzese G, Scaglione CL, Fabbrini G, Ferrazzano G, Peluso S, Pellicciari R, Gigante AF, Cossu G, Arca R, Avanzino L, Bono F, Mazza MR, Bertolasi L, Bacchin R, Eleopra R, Lettieri C, Morgante F, Altavista MC, Polidori L, Liguori R, Misceo S, Squintani G, Tinazzi M, Ceravolo R, Unti E, Magistrelli L, Coletti Moja M, Modugno N, Petracca M, Tambasco N, Cotelli MS, Aguggia M, Pisani A, Romano M, Zibetti M, Bentivoglio AR, Albanese A, Girlanda P, Berardelli A.

Neurol Sci. 2018 May;39(5):975. doi: 10.1007/s10072-018-3395-1.

PMID:
29687311
8.

Modulation of the Muscle Activity During Sleep in Cervical Dystonia.

Antelmi E, Ferri R, Provini F, Scaglione CML, Mignani F, Rundo F, Vandi S, Fabbri M, Pizza F, Plazzi G, Martinelli P, Liguori R.

Sleep. 2017 Jul 1;40(7). doi: 10.1093/sleep/zsx088.

PMID:
28525628
9.

Spine Topographical Distribution of Skin α-Synuclein Deposits in Idiopathic Parkinson Disease.

Donadio V, Incensi A, Rizzo G, Scaglione C, Capellari S, Fileccia E, Avoni P, Liguori R.

J Neuropathol Exp Neurol. 2017 May 1;76(5):384-389. doi: 10.1093/jnen/nlx021.

PMID:
28402459
10.

The Italian Dystonia Registry: rationale, design and preliminary findings.

Defazio G, Esposito M, Abbruzzese G, Scaglione CL, Fabbrini G, Ferrazzano G, Peluso S, Pellicciari R, Gigante AF, Cossu G, Arca R, Avanzino L, Bono F, Mazza MR, Bertolasi L, Bacchin R, Eleopra R, Lettieri C, Morgante F, Altavista MC, Polidori L, Liguori R, Misceo S, Squintani G, Tinazzi M, Ceravolo R, Unti E, Magistrelli L, Coletti Moja M, Modugno N, Petracca M, Tambasco N, Cotelli MS, Aguggia M, Pisani A, Romano M, Zibetti M, Bentivoglio AR, Albanese A, Girlanda P, Berardelli A.

Neurol Sci. 2017 May;38(5):819-825. doi: 10.1007/s10072-017-2839-3. Epub 2017 Feb 18. Erratum in: Neurol Sci. 2018 Apr 18;:.

PMID:
28215037
11.

Direct measurement of catalase activity in living cells and tissue biopsies.

Scaglione CN, Xu Q, Ramanujan VK.

Biochem Biophys Res Commun. 2016 Jan 29;470(1):192-196. doi: 10.1016/j.bbrc.2016.01.026. Epub 2016 Jan 6.

12.

Behçet disease presenting with movement disorders and antibasal ganglia antibodies.

Rizzo G, Licchetta L, Scaglione C, Buttiglione M, Capellari S, Martinelli P, Martino D.

Autoimmun Rev. 2016 Mar;15(3):287-8. doi: 10.1016/j.autrev.2015.11.011. Epub 2015 Nov 27. No abstract available.

PMID:
26640160
13.

A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia.

Bartoletti-Stella A, Chiaro G, Calandra-Buonaura G, Contin M, Scaglione C, Barletta G, Cecere A, Garagnani P, Tieri P, Ferrarini A, Piras S, Franceschi C, Delledonne M, Cortelli P, Capellari S.

J Neurol. 2015 Oct;262(10):2373-81. doi: 10.1007/s00415-015-7896-z. Epub 2015 Sep 26.

PMID:
26410747
14.

Skin biopsy and I-123 MIBG scintigraphy findings in idiopathic Parkinson's disease and parkinsonism: a comparative study.

Giannoccaro MP, Donadio V, Incensi A, Pizza F, Cason E, Di Stasi V, Martinelli P, Scaglione C, Capellari S, Treglia G, Liguori R.

Mov Disord. 2015 Jun;30(7):986-9. doi: 10.1002/mds.26189. Epub 2015 Mar 17.

PMID:
25778097
15.

Primary familial brain calcification: Genetic analysis and clinical spectrum.

Taglia I, Mignarri A, Olgiati S, Menci E, Petrocelli PL, Breedveld GJ, Scaglione C, Martinelli P, Federico A, Bonifati V, Dotti MT.

Mov Disord. 2014 Nov;29(13):1691-5. doi: 10.1002/mds.26053. Epub 2014 Oct 4. Erratum in: Mov Disord. 2015 Jun;30(7):1010.

PMID:
25284758
16.

Arylsulphatase A activity in familial parkinsonism: a pathogenetic role?

Antelmi E, Rizzo G, Fabbri M, Capellari S, Scaglione C, Martinelli P.

J Neurol. 2014 Sep;261(9):1803-9. doi: 10.1007/s00415-014-7425-5. Epub 2014 Jul 3. Erratum in: J Neurol. 2014 Sep;261(9):1810.

PMID:
24989669
17.

Changing the research landscape: the New York City Clinical Data Research Network.

Kaushal R, Hripcsak G, Ascheim DD, Bloom T, Campion TR Jr, Caplan AL, Currie BP, Check T, Deland EL, Gourevitch MN, Hart R, Horowitz CR, Kastenbaum I, Levin AA, Low AF, Meissner P, Mirhaji P, Pincus HA, Scaglione C, Shelley D, Tobin JN; NYC-CDRN.

J Am Med Inform Assoc. 2014 Jul-Aug;21(4):587-90. doi: 10.1136/amiajnl-2014-002764. Epub 2014 May 12.

18.

Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.

Donadio V, Incensi A, Leta V, Giannoccaro MP, Scaglione C, Martinelli P, Capellari S, Avoni P, Baruzzi A, Liguori R.

Neurology. 2014 Apr 15;82(15):1362-9. doi: 10.1212/WNL.0000000000000316. Epub 2014 Mar 14.

PMID:
24634456
19.

Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".

Fabbri M, Superbo M, Defazio G, Scaglione CL, Antelmi E, Basini G, Nassetti S, Pizza F, Plasmati R, Liguori R.

Neurol Sci. 2014 Jul;35(7):1053-8. doi: 10.1007/s10072-014-1642-7. Epub 2014 Jan 30.

PMID:
24477322
20.

Neurosyphilis orofacial dyskinesia: the candy sign.

Martinelli P, Rizzo G, Scaglione C, Capellari S.

Mov Disord. 2013 Feb;28(2):246-7. doi: 10.1002/mds.25281. Epub 2012 Nov 19. No abstract available.

PMID:
23166011
21.

From ritual sword duel to electrophysiology: hyperactive facial motor nucleus in hemifacial spasm.

Martinelli P, Scaglione C, Rizzo G, Capellari S.

Mov Disord. 2012 Jun;27(7):927-8. doi: 10.1002/mds.24986. Epub 2012 Apr 12. No abstract available.

PMID:
22499336
22.

Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?

La Morgia C, Barboni P, Rizzo G, Carbonelli M, Savini G, Scaglione C, Capellari S, Bonazza S, Giannoccaro MP, Calandra-Buonaura G, Liguori R, Cortelli P, Martinelli P, Baruzzi A, Carelli V.

Eur J Neurol. 2013 Jan;20(1):198-201. doi: 10.1111/j.1468-1331.2012.03701.x. Epub 2012 Mar 21.

PMID:
22436028
23.

Group I nonreciprocal inhibition in restless legs syndrome secondary to chronic renal failure.

Marconi S, Scaglione C, Pizza F, Rizzo G, Plazzi G, Vetrugno R, La Manna G, Campieri C, Stefoni S, Montagna P, Martinelli P.

Parkinsonism Relat Disord. 2012 May;18(4):362-6. doi: 10.1016/j.parkreldis.2011.12.002. Epub 2011 Dec 23.

PMID:
22197122
24.

Eating disorder as a psychiatric onset of juvenile Huntington's disease.

Marconi S, Rizzo G, Capellari S, Scaglione C, Cortelli P, Martinelli P, Bonazza S.

Am J Psychiatry. 2011 Oct;168(10):1120-1. doi: 10.1176/appi.ajp.2011.11020312. No abstract available.

PMID:
21969052
25.

Did goethe describe attention deficit hyperactivity disorder?

Bonazza S, Scaglione C, Poppi M, Rizzo G.

Eur Neurol. 2011;65(2):70-1. doi: 10.1159/000323426. Epub 2011 Jan 18.

26.

The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease.

Lopane G, Contin M, Scaglione C, Albani F, Baruzzi A, Martinelli P.

Clin Neuropharmacol. 2010 Sep-Oct;33(5):254-6. doi: 10.1097/WNF.0b013e3181f5328c.

PMID:
20852413
27.

Benign tremulous parkinsonism in a patient with dardarin mutation.

Rizzo G, Marconi S, Capellari S, Scaglione C, Martinelli P.

Mov Disord. 2009 Jul 15;24(9):1399-401. doi: 10.1002/mds.22544. No abstract available.

PMID:
19373934
28.

The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease.

Contin M, Martinelli P, Scaglione C, Avoni P, Albani F, Riva R, Baruzzi A.

Clin Neuropharmacol. 2008 Sep-Oct;31(5):267-71. doi: 10.1097/WNF.0b013e31815c39aa.

PMID:
18836344
29.

Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.

Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, Malucelli E, Capellari S, Testa C, Parchi P, Montagna P, Barbiroli B, Lodi R.

Brain. 2008 Oct;131(Pt 10):2690-700. doi: 10.1093/brain/awn195. Epub 2008 Sep 26.

PMID:
18819991
30.

Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients.

Vitale C, Ciotti P, Gulli R, Bellone E, Scaglione C, Abbruzzese G, Martinelli P, Barone P, Mandich P.

Parkinsonism Relat Disord. 2009 Feb;15(2):162-3. doi: 10.1016/j.parkreldis.2008.04.035. Epub 2008 Jun 16. No abstract available.

PMID:
18556235
31.

DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients.

Vitale C, Gulli R, Ciotti P, Scaglione C, Bellone E, Avanzino L, Lantieri F, Abbruzzese G, Martinelli P, Barone P, Mandich P.

Eur J Neurol. 2008 Sep;15(9):985-7. doi: 10.1111/j.1468-1331.2008.02164.x. Epub 2008 May 15.

PMID:
18484990
32.

PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum.

Marongiu R, Ferraris A, Ialongo T, Michiorri S, Soleti F, Ferrari F, Elia AE, Ghezzi D, Albanese A, Altavista MC, Antonini A, Barone P, Brusa L, Cortelli P, Martinelli P, Pellecchia MT, Pezzoli G, Scaglione C, Stanzione P, Tinazzi M, Zecchinelli A, Zeviani M, Cassetta E, Garavaglia B, Dallapiccola B, Bentivoglio AR, Valente EM; Italian PD Study Group.

Hum Mutat. 2008 Apr;29(4):565. doi: 10.1002/humu.20719.

PMID:
18330912
33.

MRI and SPECT of midbrain and striatal degeneration in fragile X-associated tremor/ataxia syndrome.

Scaglione C, Ginestroni A, Vella A, Dotti MT, Nave RD, Rizzo G, De Cristofaro MT, De Stefano N, Piacentini S, Martinelli P, Mascalchi M.

J Neurol. 2008 Jan;255(1):144-6. Epub 2007 Dec 19. No abstract available.

PMID:
18080849
34.

Group I nonreciprocal inhibition in primary restless legs syndrome.

Scaglione C, Vetrugno R, Plazzi G, Rizzo G, Provini F, Montagna P, Martinelli P.

Mov Disord. 2008 Jan;23(1):96-100.

PMID:
17987650
35.

Neuropsychological exploration of alleged mold neurotoxicity.

Reinhard MJ, Satz P, Scaglione CA, D'Elia LF, Rassovsky Y, Arita AA, Hinkin CH, Thrasher D, Ordog G.

Arch Clin Neuropsychol. 2007 May;22(4):533-43. Epub 2007 May 22.

36.

[Primary cutaneous aspergillosis in a leukemic child].

Torrelo A, Hernández-Martín A, Scaglione C, Madero L, Colmenero I, Zambrano A.

Actas Dermosifiliogr. 2007 May;98(4):276-8. Spanish.

PMID:
17506961
37.

Diffusion-weighted imaging study of patients with essential tremor.

Martinelli P, Rizzo G, Manners D, Tonon C, Pizza F, Testa C, Scaglione C, Barbiroli B, Lodi R.

Mov Disord. 2007 Jun 15;22(8):1182-5.

PMID:
17469200
38.

Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.

Contin M, Martinelli P, Albani F, Scaglione C, Avoni P, Rizzo G, Baruzzi A.

Clin Neuropharmacol. 2007 Mar-Apr;30(2):122-4. No abstract available.

PMID:
17414945
39.

Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.

Lassaletta A, Perez-Olleros P, Scaglione C, Sirvent S, De Prada I, Perez-Martinez A, Ruiz-Hernandez A, Madero L.

J Neurooncol. 2007 Jul;83(3):303-6. Epub 2007 Jan 24.

PMID:
17245619
40.

Transient left ventricular apical ballooning at the onset of multiple system atrophy.

Ripa S, Scaglione C, Rusconi LC.

J Cardiovasc Med (Hagerstown). 2006 Aug;7(8):631-6.

PMID:
16858244
41.

A case of fragile X premutation tremor/ataxia syndrome with evidence of mitochondrial dysfunction.

Rizzo G, Pizza F, Scaglione C, Tonon C, Lodi R, Barbiroli B, Ambrosetto P, Martinelli P.

Mov Disord. 2006 Sep;21(9):1541-2. No abstract available.

PMID:
16830323
42.

Parkinsonism in Caplan's syndrome.

Rizzo G, Scaglione C, Lopane G, Pollini A, Tommasoni E, Martinelli P.

Neurol Sci. 2006 Apr;27(1):67-9.

PMID:
16688603
43.

Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.

Marongiu R, Ghezzi D, Ialongo T, Soleti F, Elia A, Cavone S, Albanese A, Altavista MC, Barone P, Brusa L, Cortelli P, Petrozzi L, Scaglione C, Stanzione P, Tinazzi M, Zeviani M, Dallapiccola B, Bentivoglio AR, Valente EM, Garavaglia B; Italian PD Study Group.

Mov Disord. 2006 Aug;21(8):1232-5.

PMID:
16622859
44.

Adult Alexander's disease without leukoencephalopathy.

Salvi F, Aoki Y, Della Nave R, Vella A, Pastorelli F, Scaglione C, Matsubara Y, Mascalchi M.

Ann Neurol. 2005 Nov;58(5):813-4. No abstract available.

PMID:
16240361
45.

PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism.

Klein C, Djarmati A, Hedrich K, Schäfer N, Scaglione C, Marchese R, Kock N, Schüle B, Hiller A, Lohnau T, Winkler S, Wiegers K, Hering R, Bauer P, Riess O, Abbruzzese G, Martinelli P, Pramstaller PP.

Eur J Hum Genet. 2005 Sep;13(9):1086-93.

46.

Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease?

Hedrich K, Pramstaller PP, Stübke K, Hiller A, Kabakci K, Purmann S, Kasten M, Scaglione C, Schwinger E, Volkmann J, Kostic V, Vieregge P, Martinelli P, Abbruzzese G, Klein C, Zühlke C.

Mov Disord. 2005 Aug;20(8):1060-2.

PMID:
15929093
47.

REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study.

Scaglione C, Vignatelli L, Plazzi G, Marchese R, Negrotti A, Rizzo G, Lopane G, Bassein L, Maestri M, Bernardini S, Martinelli P, Abbruzzese G, Calzetti S, Bonuccelli U, Provini F, Coccagna G; Bologna, Genova, Parma and Pisa Universities group for the study of REM Sleep Behavior Disorder in Parkinson's Disease.

Neurol Sci. 2005 Feb;25(6):316-21.

PMID:
15729494
48.

Mutational analysis of parkin gene by denaturing high-performance liquid chromatography (DHPLC) in essential tremor.

Pigullo S, De Luca A, Barone P, Marchese R, Bellone E, Colosimo A, Scaglione C, Martinelli P, Di Maria E, Pizzuti A, Abbruzzese G, Dallapiccola B, Ajmar F, Mandich P.

Parkinsonism Relat Disord. 2004 Aug;10(6):357-62.

PMID:
15261877
49.

Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.

Contin M, Martinelli P, Mochi M, Albani F, Riva R, Scaglione C, Dondi M, Fanti S, Pettinato C, Baruzzi A.

Clin Neuropharmacol. 2004 May-Jun;27(3):111-5.

PMID:
15190232
50.

[Splenic and bone marrow increased 18F-FDG uptake in a PET scan performed following treatment with G-CSF].

Ruiz-Hernández G, Scaglione C, Delgado-Bolton RC, Gutiérrez-García A, Madero L, Jiménez-Vicioso A, Carreras-Delgado JL.

Rev Esp Med Nucl. 2004 Mar-Apr;23(2):124-6. Spanish.

PMID:
15000944

Supplemental Content

Loading ...
Support Center